Anthropic CEO Dario Amodei says AI could help make diseases such as cancer, Alzheimer’s, and heart disease “relics of the past” in about 10 years, framing the claim as part of a broader push to speed up biology and drug discovery. Multiple outlets report Amodei’s optimism and his view that faster research could transform healthcare outcomes.
Several articles add that Anthropic is pursuing work in collaboration with biotechnology firms, aiming to accelerate drug discovery efforts and exploring advances such as T-cell therapies and antibody design. One report also says Anthropic is researching its own drug innovations, noting that related studies are still at preclinical stages rather than in clinical trials.
Other coverage places greater emphasis on caution from industry figures. NDTV and one other outlet highlight pharmaceutical executives’ and scientists’ skepticism, pointing to the role of clinical trials and regulatory hurdles, as well as the uncertainty of translating faster discovery into cures within the same timeframe.
